» Articles » PMID: 10531005

Cyclin D1 Production in Cycling Cells Depends on Ras in a Cell-cycle-specific Manner

Overview
Journal Curr Biol
Publisher Cell Press
Specialty Biology
Date 1999 Oct 26
PMID 10531005
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cellular Ras and cyclin D1 are required at similar times of the cell cycle in quiescent NIH3T3 cells that have been induced to proliferate, but not in the case of cycling NIH3T3 cells. In asynchronous cultures, Ras activity has been found to be required only during G2 phase to promote passage through the entire upcoming cell cycle, whereas cyclin D1 is required through G1 phase until DNA synthesis begins. To explain these results in molecular terms, we propose a model whereby continuous cell cycle progression in NIH3T3 cells requires cellular Ras activity to promote the synthesis of cyclin D1 during G2 phase. Cyclin D1 expression then continues through G1 phase independently of Ras activity, and drives the G1-S phase transition.

Results: We found high levels of cyclin D1 expression during the G2, M and G1 phases of the cell cycle in cycling NIH3T3 cells, using quantitative fluorescent antibody measurements of individual cells. By microinjecting anti-Ras antibody, we found that the induction of cyclin D1 expression beginning in G2 phase was dependent on Ras activity. Consistent with our model, cyclin D1 expression during G1 phase was particularly stable following neutralization of cellular Ras. Finally, ectopic expression of cyclin D1 largely overcame the requirement for cellular Ras activity during the continuous proliferation of cycling NIH3T3 cells.

Conclusions: Ras-dependent induction of cyclin D1 expression beginning in G2 phase is critical for continuous cell cycle progression in NIH3T3 cells.

Citing Articles

Emerging Role of the DREAM Complex in Cancer and Therapeutic Opportunities.

Hwang Y, Kim M Int J Mol Sci. 2025; 26(1.

PMID: 39796178 PMC: 11719884. DOI: 10.3390/ijms26010322.


The MYC-NFATC2 axis maintains the cell cycle and mitochondrial function in acute myeloid leukaemia cells.

Patterson S, Massett M, Huang X, Jorgensen H, Michie A Mol Oncol. 2024; 18(9):2234-2254.

PMID: 38459421 PMC: 11467801. DOI: 10.1002/1878-0261.13630.


Unveiling the therapeutic potential of thymol from Nigella sativa L. seed: selective anticancer action against human breast cancer cells (MCF-7) through down-regulation of Cyclin D1 and proliferative cell nuclear antigen (PCNA) expressions.

Vahitha V, Lali G, Prasad S, Karuppiah P, Karunakaran G, Alsalhi M Mol Biol Rep. 2024; 51(1):61.

PMID: 38170326 DOI: 10.1007/s11033-023-09032-w.


Differential cell cycle checkpoint evasion by PTEN germline mutations associated with dichotomous phenotypes of cancer versus autism spectrum disorder.

Hitomi M, Venegas J, Kang S, Eng C Oncogene. 2023; 42(50):3698-3707.

PMID: 37907589 DOI: 10.1038/s41388-023-02867-4.


Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4/CyclinD1-pRB-E2F1 pathway.

Wang J, Zhang J, Ma Q, Zhang S, Ma F, Su W J Cell Mol Med. 2023; 27(7):991-1005.

PMID: 36915230 PMC: 10064037. DOI: 10.1111/jcmm.17716.